45 research outputs found
Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients
OBJECTIVE: CD5 plays a crucial role in autoimmunity and is a well-established genetic risk factor of developing RA. Recently, evidence of positive selection has been provided for the CD5 Pro224-Val471 haplotype in East Asian populations. The aim of the present work was to further analyze the functional relevance of non-synonymous CD5 polymorphisms conforming the ancestral and the newly derived haplotypes (Pro224-Ala471 and Pro224-Val471, respectively) as well as to investigate the potential role of CD5 on the development of SLE and/or SLE nephritis.
METHODS: The CD5 SNPs rs2241002 (C/T; Pro224Leu) and rs2229177 (C/T; Ala471Val) were genotyped using TaqMan allelic discrimination assays in a total of 1,324 controls and 681 SLE patients of Spanish origin. In vitro analysis of CD3-mediated T cell proliferative and cytokine response profiles of healthy volunteers homozygous for the above mentioned CD5 haplotypes were also analyzed.
RESULTS: T-cell proliferation and cytokine release were significantly increased showing a bias towards to a Th2 profile after CD3 cross-linking of peripheral mononuclear cells from healthy individuals homozygous for the ancestral Pro224-Ala471 (CC) haplotype, compared to the more recently derived Pro224-Val471 (CT). The same allelic combination was statistically associated with Lupus nephritis.
CONCLUSION: The ancestral Ala471 CD5 allele confers lymphocyte hyper-responsiveness to TCR/CD3 cross-linking and is associated with nephritis in SLE patients
Discrete Flavour Groups, \theta_13 and Lepton Flavour Violation
Discrete flavour groups have been studied in connection with special patterns
of neutrino mixing suggested by the data, such as Tri-Bimaximal mixing (groups
A4, S4...) or Bi-Maximal mixing (group S4...) etc. We review the predictions
for sin(\theta_13) in a number of these models and confront them with the
experimental measurements. We compare the performances of the different classes
of models in this respect. We then consider, in a supersymmetric framework, the
important implications of these flavour symmetries on lepton flavour violating
processes, like \mu -> e gamma and similar processes. We discuss how the
existing limits constrain these models, once their parameters are adjusted so
as to optimize the agreement with the measured values of the mixing angles. In
the simplified CMSSM context, adopted here just for indicative purposes, the
small tan(beta) range and heavy SUSY mass scales are favoured by lepton flavour
violating processes, which makes it even more difficult to reproduce the
reported muon g-2 discrepancy.Comment: 45 pages, 16 figures, 3 tables; V3 submitted to add an acknowledgment
to a Networ
Spontaneous Breathing in Early Acute Respiratory Distress Syndrome: Insights From the Large Observational Study to UNderstand the Global Impact of Severe Acute Respiratory FailurE Study
OBJECTIVES: To describe the characteristics and outcomes of patients with acute respiratory distress syndrome with or without spontaneous breathing and to investigate whether the effects of spontaneous breathing on outcome depend on acute respiratory distress syndrome severity. DESIGN: Planned secondary analysis of a prospective, observational, multicentre cohort study. SETTING: International sample of 459 ICUs from 50 countries. PATIENTS: Patients with acute respiratory distress syndrome and at least 2 days of invasive mechanical ventilation and available data for the mode of mechanical ventilation and respiratory rate for the 2 first days. INTERVENTIONS: Analysis of patients with and without spontaneous breathing, defined by the mode of mechanical ventilation and by actual respiratory rate compared with set respiratory rate during the first 48 hours of mechanical ventilation. MEASUREMENTS AND MAIN RESULTS: Spontaneous breathing was present in 67% of patients with mild acute respiratory distress syndrome, 58% of patients with moderate acute respiratory distress syndrome, and 46% of patients with severe acute respiratory distress syndrome. Patients with spontaneous breathing were older and had lower acute respiratory distress syndrome severity, Sequential Organ Failure Assessment scores, ICU and hospital mortality, and were less likely to be diagnosed with acute respiratory distress syndrome by clinicians. In adjusted analysis, spontaneous breathing during the first 2 days was not associated with an effect on ICU or hospital mortality (33% vs 37%; odds ratio, 1.18 [0.92-1.51]; p = 0.19 and 37% vs 41%; odds ratio, 1.18 [0.93-1.50]; p = 0.196, respectively ). Spontaneous breathing was associated with increased ventilator-free days (13 [0-22] vs 8 [0-20]; p = 0.014) and shorter duration of ICU stay (11 [6-20] vs 12 [7-22]; p = 0.04). CONCLUSIONS: Spontaneous breathing is common in patients with acute respiratory distress syndrome during the first 48 hours of mechanical ventilation. Spontaneous breathing is not associated with worse outcomes and may hasten liberation from the ventilator and from ICU. Although these results support the use of spontaneous breathing in patients with acute respiratory distress syndrome independent of acute respiratory distress syndrome severity, the use of controlled ventilation indicates a bias toward use in patients with higher disease severity. In addition, because the lack of reliable data on inspiratory effort in our study, prospective studies incorporating the magnitude of inspiratory effort and adjusting for all potential severity confounders are required
Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries
Background: To better understand the epidemiology and patterns of tracheostomy practice for patients with acute respiratory distress syndrome (ARDS), we investigated the current usage of tracheostomy in patients with ARDS recruited into the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG-SAFE) study. Methods: This is a secondary analysis of LUNG-SAFE, an international, multicenter, prospective cohort study of patients receiving invasive or noninvasive ventilation in 50 countries spanning 5 continents. The study was carried out over 4 weeks consecutively in the winter of 2014, and 459 ICUs participated. We evaluated the clinical characteristics, management and outcomes of patients that received tracheostomy, in the cohort of patients that developed ARDS on day 1-2 of acute hypoxemic respiratory failure, and in a subsequent propensity-matched cohort. Results: Of the 2377 patients with ARDS that fulfilled the inclusion criteria, 309 (13.0%) underwent tracheostomy during their ICU stay. Patients from high-income European countries (n = 198/1263) more frequently underwent tracheostomy compared to patients from non-European high-income countries (n = 63/649) or patients from middle-income countries (n = 48/465). Only 86/309 (27.8%) underwent tracheostomy on or before day 7, while the median timing of tracheostomy was 14 (Q1-Q3, 7-21) days after onset of ARDS. In the subsample matched by propensity score, ICU and hospital stay were longer in patients with tracheostomy. While patients with tracheostomy had the highest survival probability, there was no difference in 60-day or 90-day mortality in either the patient subgroup that survived for at least 5 days in ICU, or in the propensity-matched subsample. Conclusions: Most patients that receive tracheostomy do so after the first week of critical illness. Tracheostomy may prolong patient survival but does not reduce 60-day or 90-day mortality. Trial registration: ClinicalTrials.gov, NCT02010073. Registered on 12 December 2013
Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database
Background: Diabetes mellitus is a common co-existing disease in the critically ill. Diabetes mellitus may reduce the risk of acute respiratory distress syndrome (ARDS), but data from previous studies are conflicting. The objective of this study was to evaluate associations between pre-existing diabetes mellitus and ARDS in critically ill patients with acute hypoxemic respiratory failure (AHRF). Methods: An ancillary analysis of a global, multi-centre prospective observational study (LUNG SAFE) was undertaken. LUNG SAFE evaluated all patients admitted to an intensive care unit (ICU) over a 4-week period, that required mechanical ventilation and met AHRF criteria. Patients who had their AHRF fully explained by cardiac failure were excluded. Important clinical characteristics were included in a stepwise selection approach (forward and backward selection combined with a significance level of 0.05) to identify a set of independent variables associated with having ARDS at any time, developing ARDS (defined as ARDS occurring after day 2 from meeting AHRF criteria) and with hospital mortality. Furthermore, propensity score analysis was undertaken to account for the differences in baseline characteristics between patients with and without diabetes mellitus, and the association between diabetes mellitus and outcomes of interest was assessed on matched samples. Results: Of the 4107 patients with AHRF included in this study, 3022 (73.6%) patients fulfilled ARDS criteria at admission or developed ARDS during their ICU stay. Diabetes mellitus was a pre-existing co-morbidity in 913 patients (22.2% of patients with AHRF). In multivariable analysis, there was no association between diabetes mellitus and having ARDS (OR 0.93 (0.78-1.11); p = 0.39), developing ARDS late (OR 0.79 (0.54-1.15); p = 0.22), or hospital mortality in patients with ARDS (1.15 (0.93-1.42); p = 0.19). In a matched sample of patients, there was no association between diabetes mellitus and outcomes of interest. Conclusions: In a large, global observational study of patients with AHRF, no association was found between diabetes mellitus and having ARDS, developing ARDS, or outcomes from ARDS. Trial registration: NCT02010073. Registered on 12 December 2013
Short-Term Outcomes of Sleeve Gastrectomy for Morbid Obesity: Does Staple Line Reinforcement Matter?
Delayed presentation of ilio-iliac arteriovenous fistula following laparoscopic cholecystectomy treated with percutaneous graft-covered stent placement
Major vascular injuries during laparoscopic cholecystectomy are rare,
usually readily apparent, and immediately treated. We report a case of
delayed presentation of a retroperitoneal vascular injury. The patient
presented with abdominal pain and increasing edema of the lower
extremities 1 year after laparoscopic cholecystectomy and was found to
have an ilio-iliac arteriovenous fistula. Endovascular treatment was
accomplished using a graft-covered polytetrafluoroethylene stent. The
patient remained free of symptoms at 1-year follow-up
Endoscopic implantation of Plexiglas (PMMA) microspheres for the treatment of GERD
Background: A gelatinous implant containing polymethylmethacrylate
(PMMA) beads is successfully used to augment the diminished thickness of
the chorium in patients with skin defects and wrinkles, The aim of the
present study was to determine whether submucosal injection of PMMA
microspheres into the lower esophageal folds decreases the severity of
symptoms and acid reflux in patients with GERD.
Methods: Endoscopic submucosal implantation of PMMA was carried out in
10 patients with GERD who were either refractory to or dependent on
proton pump inhibitors. Symptom severity score, 24-hour pH monitoring,
upper GI endoscopy, and EUS were performed to evaluate the efficacy of
implantation.
Results: A significant decrease in the symptom severity score and mean
total time with esophageal pH less than 4 was noted after the
implantation of PMMA (p < 0.05). Seven of 10 patients were taking no
medication after PMMA implantation, There were no serious
procedure-related complications.
Conclusions: Endoscopic implantation of PMMA into the submucosa of the
lower esophageal folds may be a new method for treating GERD, Further
studies are required to determine the longterm efficacy of the
procedure
Laparoscopic versus open splenectomy in patients with beta thalassemia major
Background: Laparoscopic splenectomy is considered the standard of care
for the removal of the spleen in benign diseases. There are not
sufficient data for the routine application of this technique in
patients with beta thalassemia major.
Materials and Methods: Twenty-eight consecutive beta thalassemia major
patients who underwent elective splenectomy were randomized for open and
laparoscopic splenectomy. Patient demographics, operative time,
intraoperative and postoperative complications, conversion rate,
transfusions, and length of stay were recorded.
Results: There was no mortality in this series. There was no difference
in complication rates between the two groups. Operative time was
markedly increased in the group treated laparoscopically, as was the
need for blood transfusions. Median hospital stay was decreased in the
laparoscopic group (5 days) compared to the open group (6.5 days).
Conclusions: Laparoscopic splenectomy in patients with beta thalassemia
major is feasible; however, it is more time consuming and bleeding
occurs more often